Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Terminated Phase 1 / 2 Trials for Etoposide (DB00773)

IndicationStatusPhase
DBCOND0028534 (Adult Acute Minimally Differentiated Myeloid Leukemia (M0))Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01342887Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTreatment